Frontlight ResearchEarly access
Trial site
Maryland Oncology Hematology
- 6running trials
- 3closed trials
The trials here
What the 9 trials at this site are about, from their registry records.
- Conditions
- Multiple myeloma2 trials
- Myeloproliferative neoplasms2 trials
- Acute myeloid leukaemia1 trial
- Colorectal cancer1 trial
- Lung cancer1 trial
- Metastatic breast cancer1 trial
- Myelodysplastic syndromes1 trial
- Pancreatic cancer1 trial
- Prostate cancer1 trial
- Phase
- Phase 25 trials
- Phase 32 trials
- Status
- Recruiting5 trials
- Completed2 trials
- Active, not recruiting1 trial
- Terminated1 trial
- Lead sponsor
- SCRI Development Innovations, LLC4 trials
- Agenus Inc.1 trial
- Celgene1 trial
- Karyopharm Therapeutics Inc1 trial
- Pfizer1 trial
- and 1 more
Running trials
Recruiting
Recruiting
Recruiting
Recruiting
Outpatient Administration of Teclistamab or Talquetamab for Multiple Myeloma
Recruiting
Active, not recruiting
Study of Selinexor in Combination With Ruxolitinib in Myelofibrosis
Recruiting at the same time
How many trials recruit for the same indication here at once. A count, not a rating.
- Multiple myeloma2 recruiting
- Colorectal cancer1 recruiting
- Lung cancer1 recruiting
- Metastatic breast cancer1 recruiting
Closed trials
Site data: ClinicalTrials.govUpdated 12 Nov 2026